Stereoselective, strong inhibition of ribonucleotide reductase from E. coli by cisplatin
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 162 (2) , 715-723
- https://doi.org/10.1016/0006-291x(89)92369-3
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- [8] Reassessment of Ellman's reagentPublished by Elsevier ,2004
- The effect of cisplatin on renal ATPase activity in vivo and in vitroCancer Chemotherapy and Pharmacology, 1985
- Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNABiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1985
- The ribonucleotide reductases — A unique group of metalloenzymes essential for cell proliferationPublished by Springer Nature ,1983
- The nature of inactivating lesions produced by platinum (II) complexes in phage λ DNAChemico-Biological Interactions, 1980
- The inhibition of malate dehydrogenase by chlorammine-platinum complexesBiochimica et Biophysica Acta (BBA) - Enzymology, 1974
- The interaction of platinum II compounds with bacteriophages T7 and R17Chemico-Biological Interactions, 1972
- Ribonucleotide Reductase of Rabbit Bone MarrowPublished by Elsevier ,1972
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969
- Enzymatic Synthesis of DeoxyribonucleotidesJournal of Biological Chemistry, 1964